WO2012173521A3 - Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе - Google Patents
Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе Download PDFInfo
- Publication number
- WO2012173521A3 WO2012173521A3 PCT/RU2012/000423 RU2012000423W WO2012173521A3 WO 2012173521 A3 WO2012173521 A3 WO 2012173521A3 RU 2012000423 W RU2012000423 W RU 2012000423W WO 2012173521 A3 WO2012173521 A3 WO 2012173521A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein kinase
- kinase inhibitors
- variants
- pharmaceutical composition
- composition based
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Abstract
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES12801171.5T ES2602797T3 (es) | 2011-06-16 | 2012-05-29 | Inhibidores de las proteínas cinasas (variantes), su utilización en el tratamiento de enfermedades oncológicas y composición farmacéutica obtenida a partir de los mismos |
AU2012269818A AU2012269818B2 (en) | 2011-06-16 | 2012-05-29 | Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon |
LTEP12801171.5T LT2743266T (lt) | 2011-06-16 | 2012-05-29 | Proteinkinazės slopikliai (variantai), jų panaudojimas onkologinių ligų gydymui ir farmacinė kompozicija jų pagrindu |
UAA201404861A UA115228C2 (ru) | 2011-06-16 | 2012-05-29 | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе |
IN635MUN2014 IN2014MN00635A (ru) | 2011-06-16 | 2012-05-29 | |
EP12801171.5A EP2743266B8 (en) | 2011-06-16 | 2012-05-29 | Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon |
EA201491356A EA026704B1 (ru) | 2011-06-16 | 2012-05-29 | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе |
RS20160956A RS55380B1 (sr) | 2011-06-16 | 2012-05-29 | Inhibitori proteinske kinaze (varijante), njihova upotreba u tretmanu onkoloških bolesti i njihova farmaceutska kompozicija |
DK12801171.5T DK2743266T3 (en) | 2011-06-16 | 2012-05-29 | Protein kinase inhibitors (VERSIONS), USE THEREOF FOR TREATMENT OF oncological diseases AND PHARMACEUTICAL COMPOSITION BASED THEN |
CA2850137A CA2850137C (en) | 2011-06-16 | 2012-05-29 | Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon |
SI201230763A SI2743266T1 (en) | 2011-06-16 | 2012-05-29 | Protein kinase inhibitors (variants), their use in the treatment of oncological diseases and the pharmaceutical composition on their basis |
US14/242,241 US9522910B2 (en) | 2011-06-16 | 2014-04-01 | Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon |
IL232357A IL232357A (en) | 2011-06-16 | 2014-04-29 | Keynes-driven proteins (variations), their use in treating cancerous diseases and pharmaceuticals containing them |
HK14109243.0A HK1195771A1 (zh) | 2011-06-16 | 2014-09-12 | 蛋白質激酶抑制劑 變體 ,其在治療腫瘤學疾病中的用途以及基於此的藥物組合物 |
HRP20161478TT HRP20161478T1 (hr) | 2011-06-16 | 2016-11-08 | Inhibitori protein kinaze (varijante), njihova upotreba za liječenje neuroloških bolesti, kao i farmaceutski pripravak koji se na njima temelji |
CY20161101178T CY1118513T1 (el) | 2011-06-16 | 2016-11-16 | Αναστολεις πρωτεϊνικης κινασης (παραλλαγες), χρηση αυτων στη θεραπεια ογκολογικων νοσων και μια φαρμακευτικη συνθεση βασισμενη σε αυτους |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011124304 | 2011-06-16 | ||
RU2011124304/04A RU2477723C2 (ru) | 2011-06-16 | 2011-06-16 | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/242,241 Continuation US9522910B2 (en) | 2011-06-16 | 2014-04-01 | Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012173521A2 WO2012173521A2 (ru) | 2012-12-20 |
WO2012173521A3 true WO2012173521A3 (ru) | 2013-03-28 |
Family
ID=47357651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU2012/000423 WO2012173521A2 (ru) | 2011-06-16 | 2012-05-29 | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе |
Country Status (22)
Country | Link |
---|---|
US (1) | US9522910B2 (ru) |
EP (1) | EP2743266B8 (ru) |
AU (1) | AU2012269818B2 (ru) |
CA (1) | CA2850137C (ru) |
CY (1) | CY1118513T1 (ru) |
DK (1) | DK2743266T3 (ru) |
EA (1) | EA026704B1 (ru) |
ES (1) | ES2602797T3 (ru) |
HK (1) | HK1195771A1 (ru) |
HR (1) | HRP20161478T1 (ru) |
HU (1) | HUE031837T2 (ru) |
IL (1) | IL232357A (ru) |
IN (1) | IN2014MN00635A (ru) |
LT (1) | LT2743266T (ru) |
PL (1) | PL2743266T3 (ru) |
PT (1) | PT2743266T (ru) |
RS (1) | RS55380B1 (ru) |
RU (1) | RU2477723C2 (ru) |
SI (1) | SI2743266T1 (ru) |
SM (1) | SMT201600398B (ru) |
UA (1) | UA115228C2 (ru) |
WO (1) | WO2012173521A2 (ru) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE035337T2 (en) | 2010-05-20 | 2018-05-02 | Array Biopharma Inc | Macrocyclic compounds as TRK kinase inhibitors |
WO2013170770A1 (zh) * | 2012-05-16 | 2013-11-21 | 上海医药集团股份有限公司 | 具有抗肿瘤活性的乙炔衍生物 |
US8859553B2 (en) * | 2012-07-30 | 2014-10-14 | Astar Biotech Llc | Protein kinase inhibitors |
CN103664787B (zh) * | 2012-09-17 | 2015-09-09 | 南京圣和药业股份有限公司 | 炔杂芳环化合物及其应用 |
CN104341416B (zh) * | 2013-07-31 | 2017-03-29 | 南京圣和药业股份有限公司 | 蛋白酪氨酸激酶抑制剂及其应用 |
US10172839B2 (en) | 2014-03-06 | 2019-01-08 | University Of Southern California | Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues |
CA2941667C (en) * | 2014-03-06 | 2023-01-03 | University Of Southern California | Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues |
CN106146391A (zh) * | 2015-04-15 | 2016-11-23 | 中国科学院上海药物研究所 | 5-芳香炔基取代的苯甲酰胺类化合物及其制备方法、药物组合物和用途 |
AR104259A1 (es) | 2015-04-15 | 2017-07-05 | Celgene Quanticel Res Inc | Inhibidores de bromodominio |
TN2018000027A1 (en) | 2015-07-16 | 2019-07-08 | Array Biopharma Inc | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors |
RU2652992C2 (ru) * | 2016-04-18 | 2018-05-04 | Общество С Ограниченной Ответственностью "Фьюжн Фарма" | Новая кристаллическая солевая форма 3-(1,2,4-триазоло[4,3-а]пиридин-3-илэтинил)-4-метил-n-(4-((4-метилпиперазин-1-ил)метил)-3-трифторметилфенил)бензамида для медицинского применения |
JOP20190077A1 (ar) | 2016-10-10 | 2019-04-09 | Array Biopharma Inc | مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret |
TWI704148B (zh) | 2016-10-10 | 2020-09-11 | 美商亞雷生物製藥股份有限公司 | 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物 |
EP3571203B1 (en) | 2017-01-18 | 2023-06-07 | Array BioPharma Inc. | Substituted pyrazolo[1,5-a]pyrazine compounds as ret kinase inhibitors |
WO2018136663A1 (en) | 2017-01-18 | 2018-07-26 | Array Biopharma, Inc. | Ret inhibitors |
JOP20190213A1 (ar) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
TWI791053B (zh) | 2017-10-10 | 2023-02-01 | 美商亞雷生物製藥股份有限公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物 |
TWI812649B (zh) | 2017-10-10 | 2023-08-21 | 美商絡速藥業公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物 |
RU2664420C1 (ru) * | 2017-10-31 | 2018-08-17 | Общество С Ограниченной Ответственностью "Фьюжн Фарма" | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ДОЗИРОВКА И СПОСОБ ЛЕЧЕНИЯ Ph+ ЛЕЙКЕМИЙ |
US11524963B2 (en) | 2018-01-18 | 2022-12-13 | Array Biopharma Inc. | Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors |
WO2019143977A1 (en) | 2018-01-18 | 2019-07-25 | Array Biopharma Inc. | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors |
WO2019143994A1 (en) | 2018-01-18 | 2019-07-25 | Array Biopharma Inc. | Substituted pyrazolyl[4,3-c]pyridinecompounds as ret kinase inhibitors |
WO2020055672A1 (en) | 2018-09-10 | 2020-03-19 | Array Biopharma Inc. | Fused heterocyclic compounds as ret kinase inhibitors |
EA202191177A1 (ru) * | 2018-11-02 | 2021-07-28 | Мерк Шарп И Доум Корп. | 2-амино-n-гетероарилникотинамиды в качестве ингибиторов nav1.8 |
KR20220009349A (ko) * | 2020-07-14 | 2022-01-24 | 보로노이바이오 주식회사 | 아릴 또는 헤테로아릴 유도체, 및 이를 유효성분으로 포함하는 키나아제 관련 질환 예방 또는 치료용 약학적 조성물 |
GB202209210D0 (en) * | 2022-06-23 | 2022-08-10 | Univ Strathclyde | Cycloaddition reactions |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007075869A2 (en) * | 2005-12-23 | 2007-07-05 | Ariad Pharmaceuticals, Inc. | Bicyclic heteroaryl compounds |
RU2340611C2 (ru) * | 2000-09-15 | 2008-12-10 | Вертекс Фармасьютикалз Инкорпорейтед | Производные пиразола, используемые в качестве ингибиторов протеинкиназы |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2422377C (en) | 2000-09-15 | 2010-04-13 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
US7709520B2 (en) | 2000-10-06 | 2010-05-04 | The Texas A&M University System | Diindolylmethane and C-substituted diindolylmethane compositions and methods for the treatment of multiple cancers |
US7435823B2 (en) | 2004-01-23 | 2008-10-14 | Amgen Inc. | Compounds and methods of use |
EP1758892B1 (en) | 2004-06-10 | 2012-10-17 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
EP1896395B1 (en) | 2005-06-24 | 2015-07-15 | Merck Sharp & Dohme Corp. | Modified malonate derivatives |
WO2007097981A2 (en) | 2006-02-16 | 2007-08-30 | Millennium Pharmaceuticals, Inc. | Alpha carbolines and uses thereof |
WO2007133560A2 (en) * | 2006-05-08 | 2007-11-22 | Ariad Pharmaceuticals, Inc. | Acetylenic heteroaryl compounds |
US7919092B2 (en) | 2006-06-13 | 2011-04-05 | Oncomed Pharmaceuticals, Inc. | Antibodies to notch receptors |
US7612085B2 (en) | 2006-07-11 | 2009-11-03 | Washington University | Sigma 2 receptor ligands and therapeutic uses therefor |
ES2446269T3 (es) | 2006-12-19 | 2014-03-06 | The Board Of Trustees Of The University Of Illinois | 3-Benzofuranil-4-indolil-maleimidas como potentes inhibidores de GSK-3 para trastornos neurodegenerativos |
AU2008266856A1 (en) | 2007-06-18 | 2008-12-24 | University Of Louisville Research Foundation, Inc. | Family of PFKFB3 inhibitors with anti-neoplastic activities |
SI2235002T1 (sl) | 2008-01-23 | 2013-06-28 | Bristol-Myers Squibb Company | Spojine 4-piridinona in njihova uporaba za zdravljenje raka |
US8211911B2 (en) | 2008-08-19 | 2012-07-03 | Guoqing Paul Chen | Compounds as kinase inhibitors |
US8188109B2 (en) | 2009-07-20 | 2012-05-29 | Naxospharma S.R.L. | Benzoquinolizinium salt derivatives as anticancer agents |
US8242282B2 (en) | 2010-05-18 | 2012-08-14 | Taipei Medical University | Histone deacetylase inhibitors |
RU2011113236A (ru) | 2011-04-07 | 2012-10-20 | Общество с ограниченной ответственностью "Фьюжн Фарма" (RU) | Новые химические соединения для лечения онкологических заболеваний |
WO2013170770A1 (zh) * | 2012-05-16 | 2013-11-21 | 上海医药集团股份有限公司 | 具有抗肿瘤活性的乙炔衍生物 |
US8859553B2 (en) | 2012-07-30 | 2014-10-14 | Astar Biotech Llc | Protein kinase inhibitors |
-
2011
- 2011-06-16 RU RU2011124304/04A patent/RU2477723C2/ru active IP Right Revival
-
2012
- 2012-05-29 PT PT128011715T patent/PT2743266T/pt unknown
- 2012-05-29 UA UAA201404861A patent/UA115228C2/ru unknown
- 2012-05-29 LT LTEP12801171.5T patent/LT2743266T/lt unknown
- 2012-05-29 DK DK12801171.5T patent/DK2743266T3/en active
- 2012-05-29 RS RS20160956A patent/RS55380B1/sr unknown
- 2012-05-29 HU HUE12801171A patent/HUE031837T2/en unknown
- 2012-05-29 PL PL12801171T patent/PL2743266T3/pl unknown
- 2012-05-29 AU AU2012269818A patent/AU2012269818B2/en active Active
- 2012-05-29 CA CA2850137A patent/CA2850137C/en active Active
- 2012-05-29 ES ES12801171.5T patent/ES2602797T3/es active Active
- 2012-05-29 WO PCT/RU2012/000423 patent/WO2012173521A2/ru active Application Filing
- 2012-05-29 SI SI201230763A patent/SI2743266T1/en unknown
- 2012-05-29 EP EP12801171.5A patent/EP2743266B8/en active Active
- 2012-05-29 EA EA201491356A patent/EA026704B1/ru unknown
- 2012-05-29 IN IN635MUN2014 patent/IN2014MN00635A/en unknown
-
2014
- 2014-04-01 US US14/242,241 patent/US9522910B2/en active Active
- 2014-04-29 IL IL232357A patent/IL232357A/en active IP Right Grant
- 2014-09-12 HK HK14109243.0A patent/HK1195771A1/zh unknown
-
2016
- 2016-11-07 SM SM201600398T patent/SMT201600398B/it unknown
- 2016-11-08 HR HRP20161478TT patent/HRP20161478T1/hr unknown
- 2016-11-16 CY CY20161101178T patent/CY1118513T1/el unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2340611C2 (ru) * | 2000-09-15 | 2008-12-10 | Вертекс Фармасьютикалз Инкорпорейтед | Производные пиразола, используемые в качестве ингибиторов протеинкиназы |
WO2007075869A2 (en) * | 2005-12-23 | 2007-07-05 | Ariad Pharmaceuticals, Inc. | Bicyclic heteroaryl compounds |
Also Published As
Publication number | Publication date |
---|---|
EA026704B1 (ru) | 2017-05-31 |
CA2850137A1 (en) | 2012-12-20 |
CY1118513T1 (el) | 2017-07-12 |
US9522910B2 (en) | 2016-12-20 |
UA115228C2 (ru) | 2017-10-10 |
IL232357A0 (en) | 2014-07-01 |
RS55380B1 (sr) | 2017-03-31 |
ES2602797T3 (es) | 2017-02-22 |
EP2743266A4 (en) | 2015-03-11 |
EA201491356A1 (ru) | 2015-01-30 |
AU2012269818B2 (en) | 2016-05-19 |
RU2477723C2 (ru) | 2013-03-20 |
SMT201600398B (it) | 2017-01-10 |
SI2743266T1 (en) | 2017-02-28 |
EP2743266B1 (en) | 2016-08-17 |
PL2743266T3 (pl) | 2017-02-28 |
HRP20161478T1 (hr) | 2016-12-16 |
DK2743266T3 (en) | 2016-12-05 |
IN2014MN00635A (ru) | 2015-07-03 |
WO2012173521A2 (ru) | 2012-12-20 |
HUE031837T2 (en) | 2017-08-28 |
PT2743266T (pt) | 2016-10-14 |
AU2012269818A1 (en) | 2014-06-26 |
US20140213592A1 (en) | 2014-07-31 |
RU2011124304A (ru) | 2012-12-27 |
IL232357A (en) | 2017-05-29 |
EP2743266A2 (en) | 2014-06-18 |
EP2743266B8 (en) | 2016-09-28 |
LT2743266T (lt) | 2016-12-12 |
HK1195771A1 (zh) | 2014-11-21 |
CA2850137C (en) | 2016-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012173521A3 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
JO2885B1 (en) | Protein kinase inhibitors | |
TN2014000128A1 (en) | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh | |
NZ764151A (en) | Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, the preparation of said compound and different solid forms thereof | |
MY170656A (en) | Kinase inhibitors | |
MX2015012822A (es) | 3-pirimidin-4-il-oxazolidin-2-onas- como inhibidores del idh mutante. | |
UA117830C2 (uk) | Похідні біпіразолу як інгібітори jak | |
AU2012214029A8 (en) | Rorgammat inhibitors | |
WO2009033033A3 (en) | Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases | |
SG10201804791UA (en) | 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof | |
MX336051B (es) | Diarilacetileno hidracido que contiene inhibidores de tirosina quinasa. | |
UA111382C2 (uk) | Інгібітори протеїнкінази | |
MX2009009786A (es) | Inhibidores de la via de hedgehog. | |
MX346186B (es) | Inhibidores de proteina cinasas. | |
MX2009011810A (es) | Tiazoles y pirazoles utiles como inhibidores de cinasa. | |
MX2009012719A (es) | Tiazoles y pirazoles utiles como inhibidores de cinasa. | |
WO2012135697A3 (en) | Novel rho kinase inhibitors and methods of use | |
PH12014501278A1 (en) | Kinase inhibitors | |
WO2007120760A3 (en) | Thiophene-carboxamides useful as inhibitors of protein kinases | |
MX2014003801A (es) | Derivados de pirimidin-4-ona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral. | |
MX2009011059A (es) | Aminopirimidinas utiles como inhibidores de cinasas. | |
WO2009045992A3 (en) | C-met protein kinase inhibitors | |
MX2014002394A (es) | Inhibidores de rock suaves, novedosos. | |
WO2011022393A3 (en) | Phosphatidylcholine transfer protein inhibitors | |
MX2011012522A (es) | Inhibidores de pirazol sustituido de proteina cinasa c-met. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12801171 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: A201404861 Country of ref document: UA |
|
ENP | Entry into the national phase |
Ref document number: 2850137 Country of ref document: CA |
|
REEP | Request for entry into the european phase |
Ref document number: 2012801171 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012801171 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 232357 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2012269818 Country of ref document: AU Date of ref document: 20120529 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 201491356 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: P-2016/0956 Country of ref document: RS |